Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Carbohydr Polym ; 288: 119378, 2022 Jul 15.
Article in English | MEDLINE | ID: mdl-35450640

ABSTRACT

Exploiting materials for nanoparticle production has never halted to address the diversity in cargos and applications. Herein, maltodextrin (MD) was selected for being economic, nontoxic, biocompatible, and biodegradable. Different MDs were modified through acetal modification, turning the polymer hydrophobic and allowing pH-dependent tunable degradability. The synthesized acetalated MD (AcMD) polymers exhibited different thermal decomposition profiles and lower glass transition temperatures. Nanoprecipitation yielded uniform AcMD nanoparticles (NPs) with diameters ranging from 141 to 258 nm. The particles were loaded with hydrophobic model drug, resveratrol (67.86% entrapment efficiency and 3.75% drug loading). The degradation and the in vitro release were studied at pH 7.4 and pH 5.0 and revealed different kinetics in dependence on the amount of cyclic/acyclic acetalation. Cell viability and cellular interaction were studied on adenocarcinoma human lung epithelial A549 and differentiated human monocytic THP-1 cells. The AcMD-NPs were well tolerated by both cell lines but exhibited different uptake behaviors.


Subject(s)
Nanoparticles , Drug Carriers/chemistry , Humans , Hydrogen-Ion Concentration , Nanoparticles/chemistry , Particle Size , Polymers/chemistry , Polysaccharides
2.
Int J Pharm ; 556: 192-199, 2019 Feb 10.
Article in English | MEDLINE | ID: mdl-30553005

ABSTRACT

Glaucoma treatment with ocular medications requires overcoming the corneal barrier to drug penetration. Liposomes have a great corneal penetration ability and affinity while suffering from poor stability and low entrapment of hydrophilic drugs accompanied by rapid drug release. This work aims to develop a new, effective and stable glaucoma medication with sustained drug release properties; Timolol maleate gelatinized core liposomes. A full factorial design was utilized to study the effects of three formulation variables on drug loading and vesicle particle size. Vesicles were prepared by the thin-film hydration method, and characterized for in-vitro drug release and stability. Intra-ocular pressure (IOP) reduction was evaluated in-vivo on glaucomatous rabbit's eyes. The safety profile was assessed using histopathological examinations. Gelatin significantly increased the drug entrapment percentage reaching 50% with a particle size of 38.81 µm. Sustained drug release was recorded compared to a marketed product and to a conventional liposomal formulation. The prepared vesicles caused the highest reduction in IOP accompanied by safe histological findings. This work provided a new, safe and effective ocular glaucoma medication; Timolol maleate gelatinized core liposomes, solving the main problems of ocular liposomal formulations of hydrophilic drugs, suitable for the pharmaceutical industry and comprising abundant and relatively cheap components.


Subject(s)
Adrenergic beta-Antagonists/administration & dosage , Glaucoma/drug therapy , Intraocular Pressure/drug effects , Timolol/administration & dosage , Adrenergic beta-Antagonists/pharmacology , Adrenergic beta-Antagonists/toxicity , Animals , Chemistry, Pharmaceutical/methods , Cornea/metabolism , Delayed-Action Preparations , Disease Models, Animal , Drug Liberation , Drug Stability , Gelatin/chemistry , Hydrophobic and Hydrophilic Interactions , Liposomes , Particle Size , Rabbits , Timolol/pharmacology , Timolol/toxicity
3.
Colloids Surf B Biointerfaces ; 167: 63-72, 2018 Jul 01.
Article in English | MEDLINE | ID: mdl-29626721

ABSTRACT

In the current study, the transdermal route has been investigated to deliver the poorly bioavailable drug; curcumin into the systemic circulation, aiming to target both superficial and subcutaneous tumors such as the breast tumors. Accordingly, different colloidal carriers viz. ultradeformable nanovesicles comprising various penetration enhancers were exploited. Curcumin-loaded deformable vesicles were prepared by the thin film hydration method followed by extrusion. Sodium cholate and Tween 80 were set as standard edge activators and Labrasol, Transcutol, limonene and oleic acid were the penetration enhancers that were evaluated for their efficacy in skin permeation. The particle size and zeta potential of the prepared vesicles were significantly affected by the type of surfactant/penetration enhancer. The polydispersity measurements showed uniform particle size distribution indicating the sufficiency of the extrusion cycles performed. Curcumin, as a hydrophobic molecule, was well accommodated within the lipid bilayers of the prepared vesicles with entrapment efficiency (EE%) percentages and drug loading percentages (DL%) as high as 93.91% and 7.04%, respectively. The ex-vivo permeation studies were performed on male albino mice skin mounted on Franz diffusion cells. Oleic acid and Transcutol exhibited comparable fluxes to sodium cholate and Tween 80 (∼16 µg cm-2 h-1), whereas the fluxes of Labrasol and limonene were significantly lower. Cytotoxicity studies were performed using MTT assay on human breast cancer cell lines (MCF-7 cells). The results of the MTT assay demonstrated that oleic acid ultradeformable nanovesicles scored an IC50 of 20 µg/ml which introduce these new curcumin-loaded nanovesicles as a successful delivery system for breast cancer therapy.


Subject(s)
Breast Neoplasms/drug therapy , Curcumin/administration & dosage , Drug Delivery Systems/methods , Nanoparticles/administration & dosage , Skin/metabolism , Administration, Cutaneous , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/chemistry , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Survival/drug effects , Curcumin/chemistry , Female , Humans , MCF-7 Cells , Male , Mice , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Particle Size , Skin Absorption
4.
Int J Biol Macromol ; 108: 753-764, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29104049

ABSTRACT

Curcumin-loaded chitosan nanoparticles intended for transdermal delivery were successfully prepared, optimized and their fate, interaction and pathway through the skin were tracked. D-optimal response surface methodology was used for the nanoparticles optimization. Xy and z-stack confocal laser scanning microscopic images were used for the particles tracking after measuring the drug permeation through the skin using Franz diffusion cells. Very small particle sizes in the range of 33.85-199.23nm accompanied with low PDI values of 0.129-0.536 of the prepared curcumin-loaded chitosan nanoparticles were obtained. TEM images revealed the spherical and non-aggregating curcumin-loaded chitosan nanoparticles. The ex-vivo permeation studies have proven the ability of the prepared chitosan nanoparticles to deliver curcumin through the skin reaching fluxes viz 5.14±1.31µgcm-2h-1. The confocal laser scanning microscopy has proven that the appendageal route is the main route of penetration of the prepared nanoparticles and has demonstrated the localization of the chitosan nanoparticles within the hair follicles from which the drug diffuses to deep layers of the skin and beyond.


Subject(s)
Chitosan , Curcumin/administration & dosage , Microscopy, Confocal , Nanoparticles , Skin Absorption , Administration, Cutaneous , Chitosan/chemistry , Chromatography, High Pressure Liquid , Curcumin/chemistry , Drug Carriers , Drug Compounding , Drug Delivery Systems , Hydrogen-Ion Concentration , Models, Statistical , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Particle Size
5.
Int J Biol Macromol ; 64: 334-40, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24355618

ABSTRACT

The aim of this study is to utilize statistical designs and mathematical modeling to end the continuous debate about the different variables that influence the production of nanoparticles using the ionic gelation method between the biopolymer chitosan (CS) and tripolyphosphate (TPP) ion. Preliminary experiments were adopted to extract the optimum conditions for the nanoparticles preparation and model construction. Critical process parameters were screened using the one-factor-at-a-time (OFAT) approach to select optimum experimental regions. Finally, these factors were optimized using two different methods of response surface modeling; the Box-Behnken and the D-optimal. The significant models showed excellent fitting of the data. The two methods were validated using a set of check points and were subsequently compared. Good agreement between actual and predicted values was obtained though the D-optimal model was more successful in predicting the particle size of the prepared nanoparticles with percentage bias as small as 1.49%. Nanoparticles were produced with diameters ranging from 52.21 nm to 400.30 nm, particle polydispersity from 0.06 to 0.40 and suitable morphology. This work provides an overview on the production of chitosan nanoparticles with desirable size enabling their successful use in drugs delivery and targeting or in any nanotechnology or interfacial application.


Subject(s)
Chitosan/chemistry , Models, Theoretical , Nanoparticles/chemistry , Hydrogen-Ion Concentration , Models, Statistical , Molecular Weight , Reproducibility of Results , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL
...